Unidentified dossier deficiencies can lead to regulatory queries, additional documentation requests, and submission delays.

Zenovel's pharmaceutical dossier due diligence approach focuses on identifying documentation gaps, evaluating technical inconsistencies, reviewing validation evidence, and assessing potential regulatory risks.

Proactive assessment gives pharmaceutical teams a clearer understanding of dossier readiness and the corrective actions needed before submission.

Zenovel — Beyond Compliance.

Learn more: https://zenovel.com/regulatory-affairs/due-diligence-of-dossier/